XENE
USDXenon Pharmaceuticals Inc. Common Shares
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$39.740
High
$40.450
Low
$37.625
Volume
0.18M
Company Fundamentals
Market Cap
3.0B
Industry
Biotechnology
Country
Canada
Trading Stats
Avg Volume
0.79M
Exchange
NGM
Currency
USD
52-Week Range
Related News
RBC Capital Maintains Outperform on Xenon Pharmaceuticals, Raises Price Target to $58
RBC Capital analyst Brian Abrahams maintains Xenon Pharmaceuticals with a Outperform and raises the price target from $55 to $58.
Wells Fargo Maintains Overweight on Xenon Pharmaceuticals, Lowers Price Target to $44
Wells Fargo analyst Benjamin Burnett maintains Xenon Pharmaceuticals with a Overweight and lowers the price target from $48 to $44.
Needham Reiterates Buy on Xenon Pharmaceuticals, Maintains $55 Price Target
Needham analyst Serge Belanger reiterates Xenon Pharmaceuticals with a Buy and maintains $55 price target.
Xenon to Report Q3 2025 Financial Results on November 3, 2025
VANCOUVER, British Columbia and BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.